Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 500

1.

How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy.

Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Höglinger GU; Movement Disorder Society-endorsed PSP Study Group.

Mov Disord. 2019 Mar 18. doi: 10.1002/mds.27666. [Epub ahead of print]

PMID:
30884545
2.

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease.

Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR & MDS Non‐Motor PD Study Group.

Mov Disord Clin Pract. 2018 Nov 8;6(1):57-64. doi: 10.1002/mdc3.12694. eCollection 2019 Jan.

PMID:
30746417
3.

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.

Dafsari HS, Martinez-Martin P, Rizos A, Trost M, Dos Santos Ghilardi MG, Reddy P, Sauerbier A, Petry-Schmelzer JN, Kramberger M, Borgemeester RWK, Barbe MT, Ashkan K, Silverdale M, Evans J, Odin P, Fonoff ET, Fink GR, Henriksen T, Ebersbach G, Pirtošek Z, Visser-Vandewalle V, Antonini A, Timmermann L, Ray Chaudhuri K; EUROPAR and the International Parkinson and Movement Disorders Society Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2019 Mar;34(3):353-365. doi: 10.1002/mds.27626. Epub 2019 Feb 4.

PMID:
30719763
4.

Deep brain stimulation for monogenic Parkinson's disease: a systematic review.

Kuusimäki T, Korpela J, Pekkonen E, Martikainen MH, Antonini A, Kaasinen V.

J Neurol. 2019 Jan 18. doi: 10.1007/s00415-019-09181-8. [Epub ahead of print] Review.

PMID:
30659355
5.

Levodopa-carbidopa intestinal gel in a subgroup of patients with dyskinesia at baseline from the GLORIA Registry.

Poewe W, Chaudhuri KR, Bergmann L, Antonini A.

Neurodegener Dis Manag. 2019 Feb;9(1):39-46. doi: 10.2217/nmt-2018-0034. Epub 2018 Dec 14.

6.

A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium.

Oppedal K, Ferreira D, Cavallin L, Lemstra AW, Ten Kate M, Padovani A, Rektorova I, Bonanni L, Wahlund LO, Engedal K, Nobili F, Kramberger M, Taylor JP, Hort J, Snædal J, Blanc F, Walker Z, Antonini A, Westman E, Aarsland D; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Mar;15(3):400-409. doi: 10.1016/j.jalz.2018.09.011. Epub 2018 Nov 12.

PMID:
30439333
7.

Burden of non-motor symptoms in Parkinson's disease patients predicts improvement in quality of life during treatment with levodopa-carbidopa intestinal gel.

Ray Chaudhuri K, Antonini A, Robieson WZ, Sanchez-Soliño O, Bergmann L, Poewe W; GLORIA study co-investigators.

Eur J Neurol. 2019 Apr;26(4):581-e43. doi: 10.1111/ene.13847. Epub 2018 Dec 26.

PMID:
30353942
8.

Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset.

Fiorenzato E, Biundo R, Cecchin D, Frigo AC, Kim J, Weis L, Strafella AP, Antonini A.

J Alzheimers Dis. 2018;66(1):229-237. doi: 10.3233/JAD-180390.

PMID:
30282359
9.

Apomorphine infusion in advanced Parkinson disease.

Antonini A, Jenner P.

Nat Rev Neurol. 2018 Dec;14(12):693-694. doi: 10.1038/s41582-018-0083-y. No abstract available.

PMID:
30279608
10.

USP14 inhibition corrects an in vivo model of impaired mitophagy.

Chakraborty J, von Stockum S, Marchesan E, Caicci F, Ferrari V, Rakovic A, Klein C, Antonini A, Bubacco L, Ziviani E.

EMBO Mol Med. 2018 Nov;10(11). pii: e9014. doi: 10.15252/emmm.201809014.

11.

Regulation of ER-mitochondria contacts by Parkin via Mfn2.

Basso V, Marchesan E, Peggion C, Chakraborty J, von Stockum S, Giacomello M, Ottolini D, Debattisti V, Caicci F, Tasca E, Pegoraro V, Angelini C, Antonini A, Bertoli A, Brini M, Ziviani E.

Pharmacol Res. 2018 Dec;138:43-56. doi: 10.1016/j.phrs.2018.09.006. Epub 2018 Sep 13.

12.

Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial.

Antonini A, Gentile G, Giglio M, Marcante A, Gage H, Touray MML, Fotiadis DI, Gatsios D, Konitsiotis S, Timotijevic L, Egan B, Hodgkins C, Biundo R, Pellicano C; PD_Manager consortium.

Trials. 2018 Sep 14;19(1):492. doi: 10.1186/s13063-018-2767-4.

13.

Disease progression in Parkinson subtypes: the PPMI dataset.

Aleksovski D, Miljkovic D, Bravi D, Antonini A.

Neurol Sci. 2018 Nov;39(11):1971-1976. doi: 10.1007/s10072-018-3522-z. Epub 2018 Aug 14.

PMID:
30109466
14.

[Duodenale levodopa and apomorphine infusion for motor complications in advanced Parkinson's disease].

Antonini A, Jost WH.

Fortschr Neurol Psychiatr. 2018 Sep;86(S 01):S5-S9. doi: 10.1055/a-0646-4164. Epub 2018 Aug 14. German.

PMID:
30107620
15.

Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson's disease: a multi-country Delphi-panel approach.

Antonini A, Stoessl AJ, Kleinman LS, Skalicky AM, Marshall TS, Sail KR, Onuk K, Odin PLA.

Curr Med Res Opin. 2018 Dec;34(12):2063-2073. doi: 10.1080/03007995.2018.1502165. Epub 2018 Aug 20.

PMID:
30016901
16.

Apomorphine and levodopa infusion for motor fluctuations and dyskinesia in advanced Parkinson disease.

Antonini A, Nitu B.

J Neural Transm (Vienna). 2018 Aug;125(8):1131-1135. doi: 10.1007/s00702-018-1906-0. Epub 2018 Jul 13. Review.

PMID:
30006821
17.

First comprehensive tool for screening pain in Parkinson's disease: the King's Parkinson's Disease Pain Questionnaire.

Martinez-Martin P, Rizos AM, Wetmore J, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR; EUROPAR and MDS Non-motor PD Study Group.

Eur J Neurol. 2018 Oct;25(10):1255-1261. doi: 10.1111/ene.13691. Epub 2018 Jun 22.

PMID:
29806962
18.

Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Odin P, Chaudhuri KR, Volkmann J, Antonini A, Storch A, Dietrichs E, Pirtošek Z, Henriksen T, Horne M, Devos D, Bergquist F.

NPJ Parkinsons Dis. 2018 May 10;4:14. doi: 10.1038/s41531-018-0051-7. eCollection 2018. Review.

19.

Interferon-beta injection site reactions in patients with multiple sclerosis.

Maurelli M, Bergamaschi R, Antonini A, Fargnoli MC, Puma E, Mallucci G, Totaro R, Girolomoni G.

J Dermatolog Treat. 2018 Dec;29(8):831-834. doi: 10.1080/09546634.2018.1467539. Epub 2018 May 7. Review.

PMID:
29671656
20.

Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease.

Dafsari HS, Weiß L, Silverdale M, Rizos A, Reddy P, Ashkan K, Evans J, Reker P, Petry-Schmelzer JN, Samuel M, Visser-Vandewalle V, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):867-874. doi: 10.1016/j.brs.2018.02.015. Epub 2018 Feb 24.

PMID:
29655587
21.

Non-motor outcomes of subthalamic stimulation in Parkinson's disease depend on location of active contacts.

Dafsari HS, Petry-Schmelzer JN, Ray-Chaudhuri K, Ashkan K, Weis L, Dembek TA, Samuel M, Rizos A, Silverdale M, Barbe MT, Fink GR, Evans J, Martinez-Martin P, Antonini A, Visser-Vandewalle V, Timmermann L; EUROPAR; IPMDS Non Motor PD Study Group.

Brain Stimul. 2018 Jul - Aug;11(4):904-912. doi: 10.1016/j.brs.2018.03.009. Epub 2018 Mar 16.

PMID:
29655586
22.

Age/disease duration influence on activities of daily living and quality of life after levodopa-carbidopa intestinal gel in Parkinson's disease.

Antonini A, Robieson WZ, Bergmann L, Yegin A, Poewe W.

Neurodegener Dis Manag. 2018 Jun;8(3):161-170. doi: 10.2217/nmt-2017-0046. Epub 2018 Apr 10.

23.

Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.

Chondrogiorgi M, Astrakas LG, Zikou AK, Weis L, Xydis VG, Antonini A, Argyropoulou MI, Konitsiotis S.

Brain Imaging Behav. 2019 Feb;13(1):232-240. doi: 10.1007/s11682-018-9863-7.

PMID:
29629498
24.

A new dermoscopic algorithm for the differential diagnosis of facial lentigo maligna and pigmented actinic keratosis.

Micantonio T, Neri L, Longo C, Grassi S, Di Stefani A, Antonini A, Coco V, Fargnoli MC, Argenziano G, Peris K.

Eur J Dermatol. 2018 Apr 1;28(2):162-168. doi: 10.1684/ejd.2018.3246.

PMID:
29620004
25.

Medical and surgical management of advanced Parkinson's disease.

Antonini A, Moro E, Godeiro C, Reichmann H.

Mov Disord. 2018 Jul;33(6):900-908. doi: 10.1002/mds.27340. Epub 2018 Mar 23. Review.

PMID:
29570862
26.

Pain in Parkinson's disease: facts and uncertainties.

Antonini A, Tinazzi M, Abbruzzese G, Berardelli A, Chaudhuri KR, Defazio G, Ferreira J, Martinez-Martin P, Trenkwalder C, Rascol O.

Eur J Neurol. 2018 Jul;25(7):917-e69. doi: 10.1111/ene.13624. Epub 2018 Apr 18. Review.

PMID:
29520899
27.

Caregiver burden and its related factors in advanced Parkinson's disease: data from the PREDICT study.

Tessitore A, Marano P, Modugno N, Pontieri FE, Tambasco N, Canesi M, Latorre A, Lopiano L, Sensi M, Quatrale R, Solla P, Defazio G, Melzi G, Costanzo AM, Gualberti G, di Luzio Paparatti U, Antonini A.

J Neurol. 2018 May;265(5):1124-1137. doi: 10.1007/s00415-018-8816-9. Epub 2018 Mar 7.

28.

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.

Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non Motor PD Study Group.

Mov Disord. 2018 Mar;33(3):421-430. doi: 10.1002/mds.27283. Epub 2018 Feb 21.

PMID:
29465787
29.

DBS for Parkinson's disease with behavioural disturbances.

Antonini A, Obeso JA.

Lancet Neurol. 2018 Mar;17(3):195-197. doi: 10.1016/S1474-4422(18)30044-9. No abstract available.

PMID:
29452675
30.

Relevance of sleep quality on caregiver burden in Parkinson's disease.

Bartolomei L, Pastore A, Meligrana L, Sanson E, Bonetto N, Minicuci GM, Marsala SZ, Mesiano T, Bragagnolo L, Antonini A.

Neurol Sci. 2018 May;39(5):835-839. doi: 10.1007/s10072-018-3252-2. Epub 2018 Feb 14.

PMID:
29445989
31.

Workers' Exposure to Nano-Objects with Different Dimensionalities in R&D Laboratories: Measurement Strategy and Field Studies.

Boccuni F, Ferrante R, Tombolini F, Lega D, Antonini A, Alvino A, Pingue P, Beltram F, Sorba L, Piazza V, Gemmi M, Porcari A, Iavicoli S.

Int J Mol Sci. 2018 Jan 24;19(2). pii: E349. doi: 10.3390/ijms19020349.

32.

Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease.

Dafsari HS, Reker P, Silverdale M, Reddy P, Pilleri M, Martinez-Martin P, Rizos A, Perrier E, Weiß L, Ashkan K, Samuel M, Evans J, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Timmermann L; EUROPAR and the IPMDS Non-Motor PD Study Group.

Neuromodulation. 2018 Aug;21(6):532-540. doi: 10.1111/ner.12740. Epub 2017 Dec 20.

PMID:
29266613
33.

Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?

Catalán MJ, Antonini A, Calopa M, Băjenaru O, de Fábregues O, Mínguez-Castellanos A, Odin P, García-Moreno JM, Pedersen SW, Pirtošek Z, Kulisevsky J.

eNeurologicalSci. 2017 Jul 2;8:44-53. doi: 10.1016/j.ensci.2017.06.004. eCollection 2017 Sep. Review.

34.

Peri-electrode edema after bilateral subthalamic deep brain stimulation for Parkinson's disease.

Trezza A, Landi A, Pilleri M, Antonini A, Giussani C, Sganzerla EP.

J Neurosurg Sci. 2018 Feb;62(1):103-105. doi: 10.23736/S0390-5616.16.03421-4. No abstract available.

PMID:
29239165
35.

Membrane cholesterol depletion in cortical neurons highlights altered NMDA receptor functionality in a mouse model of amyotrophic lateral sclerosis.

Antonini A, Caioli S, Saba L, Vindigni G, Biocca S, Canu N, Zona C.

Biochim Biophys Acta Mol Basis Dis. 2018 Feb;1864(2):509-519. doi: 10.1016/j.bbadis.2017.11.008. Epub 2017 Nov 24.

36.

Quality of life outcome after subthalamic stimulation in Parkinson's disease depends on age.

Dafsari HS, Reker P, Stalinski L, Silverdale M, Rizos A, Ashkan K, Barbe MT, Fink GR, Evans J, Steffen J, Samuel M, Dembek TA, Visser-Vandewalle V, Antonini A, Ray-Chaudhuri K, Martinez-Martin P, Timmermann L; EUROPAR and the IPMDS (International Parkinson's and Movement Disorders Society) Non-Motor Parkinson's Disease Study Group.

Mov Disord. 2018 Jan;33(1):99-107. doi: 10.1002/mds.27222. Epub 2017 Nov 18.

PMID:
29150860
37.

The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging.

Bellucci A, Antonini A, Pizzi M, Spano P.

Front Aging Neurosci. 2017 Oct 10;9:330. doi: 10.3389/fnagi.2017.00330. eCollection 2017.

38.

Heterogeneity of BRAF, NRAS, and TERT Promoter Mutational Status in Multiple Melanomas and Association with MC1R Genotype: Findings from Molecular and Immunohistochemical Analysis.

Pellegrini C, Di Nardo L, Cipolloni G, Martorelli C, De Padova M, Antonini A, Maturo MG, Del Regno L, Strafella S, Micantonio T, Leocata P, Peris K, Fargnoli MC.

J Mol Diagn. 2018 Jan;20(1):110-122. doi: 10.1016/j.jmoldx.2017.10.002. Epub 2017 Oct 20.

PMID:
29061376
39.

Predicting rapid progression of Parkinson's Disease at baseline patients evaluation.

Tsiouris KM, Rigas G, Gatsios D, Antonini A, Konitsiotis S, Koutsouris DD, Fotiadis DI.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:3898-3901. doi: 10.1109/EMBC.2017.8037708.

PMID:
29060749
40.

Testing feasibility of an accurate microscopic assessment of macrovesicular steatosis in liver allograft biopsies by smartphone add-on lenses.

Cesaretti M, Poté N, Dondero F, Cauchy F, Schneck AS, Soubrane O, Paradis V, Diaspro A, Antonini A.

Microsc Res Tech. 2018 Jan;81(1):58-63. doi: 10.1002/jemt.22956. Epub 2017 Oct 17.

PMID:
29044859
41.

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry.

Antonini A, Poewe W, Chaudhuri KR, Jech R, Pickut B, Pirtošek Z, Szasz J, Valldeoriola F, Winkler C, Bergmann L, Yegin A, Onuk K, Barch D, Odin P; GLORIA study co-investigators.

Parkinsonism Relat Disord. 2017 Dec;45:13-20. doi: 10.1016/j.parkreldis.2017.09.018. Epub 2017 Sep 22.

42.

The peroneus brevis flap in the treatment of bone infections of the lower limb.

Antonini A, Rossello C, Salomone C, Riccio G, Felli L, Burastero G.

Injury. 2017 Oct;48 Suppl 3:S76-S79. doi: 10.1016/S0020-1383(17)30663-0.

PMID:
29025616
43.

Nutritional habits, risk, and progression of Parkinson disease.

Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M.

J Neurol. 2018 Jan;265(1):12-23. doi: 10.1007/s00415-017-8639-0. Epub 2017 Oct 10. Review.

PMID:
29018983
44.

Below Knee Stump Reconstruction with a Foot Fillet Flap.

Tos P, Antonini A, Pugliese P, Panero B, Ciclamini D, Battiston B.

J Reconstr Microsurg. 2017 Oct;33(S 01):S20-S26. doi: 10.1055/s-0037-1606538. Epub 2017 Oct 6. No abstract available.

PMID:
28985635
45.

Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible?

Biundo R, Weis L, Fiorenzato E, Antonini A.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):840-860. doi: 10.1093/arclin/acx092. Review.

PMID:
28961738
46.

Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study.

Biundo R, Weis L, Abbruzzese G, Calandra-Buonaura G, Cortelli P, Jori MC, Lopiano L, Marconi R, Matinella A, Morgante F, Nicoletti A, Tamburini T, Tinazzi M, Zappia M, Vorovenci RJ, Antonini A.

Mov Disord. 2017 Nov;32(11):1557-1565. doi: 10.1002/mds.27181. Epub 2017 Sep 27.

PMID:
28960475
47.

Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease.

Fabbri M, Guimarães I, Cardoso R, Coelho M, Guedes LC, Rosa MM, Godinho C, Abreu D, Gonçalves N, Antonini A, Ferreira JJ.

Front Neurol. 2017 Aug 22;8:432. doi: 10.3389/fneur.2017.00432. eCollection 2017.

48.

The Propeller Concept Applied to Free Flaps and the Proposal of a "Clock Flap" Nomenclature.

Antonini A, Rossello C, Salomone C, Carrega G, Felli L, Burastero G.

J Reconstr Microsurg. 2017 Oct;33(S 01):S48-S52. doi: 10.1055/s-0037-1606269. Epub 2017 Aug 25. No abstract available.

PMID:
28841734
49.

Real-Time Rain Rate Evaluation via Satellite Downlink Signal Attenuation Measurement.

Giannetti F, Reggiannini R, Moretti M, Adirosi E, Baldini L, Facheris L, Antonini A, Melani S, Bacci G, Petrolino A, Vaccaro A.

Sensors (Basel). 2017 Aug 12;17(8). pii: E1864. doi: 10.3390/s17081864.

50.

Understanding and Treating Pain Syndromes in Parkinson's Disease.

Gandolfi M, Geroin C, Antonini A, Smania N, Tinazzi M.

Int Rev Neurobiol. 2017;134:827-858. doi: 10.1016/bs.irn.2017.05.013. Epub 2017 Jul 3. Review.

PMID:
28805585

Supplemental Content

Loading ...
Support Center